BridgeMD
New treatment option for Ankle Fractures
Official title The Benefit of Repairing the Deltoid Ligament in Unstable Ankle Fractures
ClinicalTrials.gov ID: NCT06568276
What this study is testing
- What it's testing
- Ankle fractures occur in 1 out of 800 persons a year and is a common injury. The deltoid ligament is necessary for the stability of the joint and guides choice of treatment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- ; fluent in oral and written Norwegian language
- isolated Weber type B fractures and Weber B+ posterior malleolar Mason Molloy class I.
- Initial medial clear space (MCS)\>=7mm or weightbearing x-ray evaluated as unstable or primary reposition after fracture dislocation.
- Pre-injury walking ability without aids.
You likely can't join if
- assumed not compliant (drug use, cognitive- and/or psychiatric disorders).
- previous history of ipsilateral ankle fracture or ipsilateral major ankle-/foot surgery.
- open fx Gustilo Anderson II or more, multi-trauma and pathologic fracture.
- neuropathies and generalized joint disease such as Rheumatoid Arthritis or other more severe condition in same extremity
- fixation of tibial fragment or syndesmotic screw or suture button planned prior to surgery
The study team makes the final eligibility decision.
Where it's taking place
- Grålum, Postbox 300, Norway
- Ålesund, Norway
- Bergen, Norway
- Bodø, Norway
- Elverum, Norway
- Gjøvik, Norway
- Levanger, Norway
- Oslo, Norway
- Stavanger, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Grålum, Postbox 300, Norway; Ålesund, Norway; Bergen, Norway; Bodø, Norway; Elverum, Norway; Gjøvik, Norway and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.